A prostate cancer-specific super-enhancer at 1q42.3 regulates the CAPN2 and KRT19.
Genetic susceptibility plays an essential role in prostate cancer (PCa) risk, while the functional mechanisms underlying several classic risk loci remain largely uncharacterized. Here, we identified a PCa specific super-enhancer within 1q42.3 locus, termed NR125945-SE, which resides within a previously reported PCa sus...